Hematology/Oncology

Top Story

H. pylori drug achieves positive results in phase 3 study

December 13, 2018
Meeting NewsPerspective

Daratumumab regimen yields durable responses in relapsed, refractory multiple myeloma

December 13, 2018
SAN DIEGO — Patients with relapsed or refractory multiple myeloma who received the addition of daratumumab to lenalidomide and dexamethasone continued to…
Meeting News

AS linked to increased risk for certain cancer types

December 12, 2018
CHICAGO — Patients with ankylosing spondylitis had an increased risk for melanoma, hematological malignancies, kidney and thyroid cancer but a reduced risk for…
In the Journals Plus

Radical prostatectomy prolongs life expectancy of men with prostate cancer

December 12, 2018
Men with clinically detected, localized prostate cancer and long life expectancies gained an average of 2.9 years of life after undergoing radical prostatectomy…
Meeting NewsPerspective

Chemotherapy, radiation may increase risk for subsequent acute lymphoblastic leukemia

December 12, 2018
SAN DIEGO — Prior cancer treatment with chemotherapy, radiation or both for was associated with an increased risk for subsequent acute lymphoblastic leukemia…
More Headlines »
CME CNE CPE

Exploring New Immune Checkpoint Inhibitor Paradigms in Advanced Melanoma

This activity is supported by an educational grant from Bristol-Myers Squibb.

The integration of immune checkpoint inhibitors into treatment algorithms for the management of advanced genitourinary…
More »
Video
Meeting News

VIDEO: Integrity chief among characteristics for succession in physician leadership

August 16, 2018
More »
Resource Centers
ASH Annual Meeting and Exposition

ASH Annual Meeting and Exposition

CME

Multimodality Treatment Strategies for NSCLC: A Symposium at the US Oncology Annual Meeting

This activity is supported by an educational grant from Merck & Co., Inc.

Lung cancer is a leading cause of cancer death worldwide. Approximately 85% of diagnosed lung cancers are non-small…
More »
Current Issues
View the Current Issue
HemOnc Today